End-of-Life Antibiotic Use After the Life-Sustaining Treatment Decisions Act in Korea

In this retrospective cohort study of patients with advanced cancer, the LSTD Act was not associated with reduced end-of-life antibiotic use, suggesting the need to reshape perceptions of antibiotics as potential life-sustaining therapy.

Corresponding Authors: Jeong-Han Kim, MD, MS, Division of Infectious Diseases, Department of Internal Medicine, Ewha Womans University College of Medicine, Mokdong Hospital, 1071, Anyangcheon-ro, Yangcheon-gu, Seoul, South Korea (wjdgks0525@gmail.com); Shin Hye Yoo, MD, PhD, Center for Palliative Care and Clinical Ethics, Seoul National University Hospital, 103 Daehak-ro, Jongno-gu, Seoul, South Korea (ifi1024@gmail.com).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.